Boehringer
Giotrif increases lung cancer survival
May 16, 2014Research and Development, Sales and Marketing Boehringer, Iressa, Roche, Tarceva, afatinib, giotrif, lung cancer
Boehringer Ingelheim is trumpeting overall survival results from a new analysis of two late-stage studies involving Giotrif in lung cancer …
Boehringer launches new transparency regime
May 12, 2014Research and Development, Sales and Marketing Boehringer, LEO Pharma, all trials, csr, transparency
Boehringer is making good on its 2013 promise to release more clinical trial data to researchers with the launch of …
Merck’s vorapaxar gains long-awaited FDA approval
May 9, 2014Sales and Marketing Boehringer, FDA, Merck, lilly, vorapaxar, zontivity
Merck’s heart drug vorapaxar has finally been given the FDA go-ahead after looking dead in the water less than two …
Bayer to make $14 bn move for Merck unit
May 2, 2014Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Boehringer, Merck, Novartis, Reckitt Benckiser, claritin, reuters
Bayer is in talks with Merck & Co to buy its consumer business and is willing to pay $14 billion …
Boehringer: ‘devil in detail’ on new drug pricing policy
April 10, 2014Medical Communications, Sales and Marketing Boehringer, PPRS, VBP, Zinta Krumins, alltrials, vba
Zinta Krumins, the newly-appointed managing director of Boehringer Ingelheim UK and Ireland, has warned that the ‘devil is in the …
CHMP recommends Jardiance
March 24, 2014Research and Development, Sales and Marketing Boehringer, CHMP, EU, diabetes, jardiance, lilly
Boehringer Ingelheim and Eli Lilly’s type 2 diabetes treatment Jardiance is among nine medicines which the Committee for Medicinal Products …
Boehringer’s first cancer drug gains NICE yes
March 17, 2014Sales and Marketing Boehringer, Cancer, NICE, NSCLC, afatinib, giotrif
NICE is recommending that Boehringer Ingelheim’s first oncology treatment Giotrif be funded by the NHS. The new final draft guidance …
Breaking into the oncology market
March 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Cancer, NSCLC, edwards, gilotrif, oncology
In many ways, the US approval of Boehringer’s Gilotrif for patients with late-stage non-small cell lung cancer (NSCLC) last year …
Manufacturing hitches cited for Lilly/BI drug rejection
March 6, 2014Manufacturing and Production, Sales and Marketing Boehringer, FDA, diabetes, lilly, manufacturing
The FDA has refused to approve a new diabetes treatment from Lilly and its partner Boehringer Ingelheim due to ongoing …
Boehringer in hot water over Pradaxa risks
February 19, 2014Sales and Marketing Boehringer, Pradaxa, Xarelto, dabigatran, lawsuit
Boehringer Ingelheim attempted to delay and revise the publication of important drug information surrounding its new anticoagulant Pradaxa. This is …
Aveo and Astellas part ways
February 17, 2014Sales and Marketing Astellas, Aveo, Boehringer, EMA, tivozanib
Aveo Oncology and Astellas Pharma are to abandon their three-year old collaboration and licence agreement for investigational tyrosine kinase inhibitor …
‘More than 2,000’ US lawsuits for Boehringer
February 14, 2014Sales and Marketing Boehringer, Pradaxa, Xarelto, blood thinner, warfarin
Boehringer Ingelheim is facing more than 2,000 lawsuits in the US over allegations that its stroke prevention pill Pradaxa has …
Boehringer launches psychiatric research project
December 23, 2013Research and Development, Sales and Marketing Boehringer, circuit, psychiatry
Boehringer Ingelheim has announced it will collaborate on a new three-year programme to investigate the neural foundations of psychiatric disorders. …
EMA speeds up Boehringer review
November 28, 2013Sales and Marketing Boehringer, faldaprevir, hepc
Boehringer Ingelheim’s hepatitis C candidate faldaprevir has moved a potential step closer to market with the news that the European …
New online tool to hear lung cancer patients’ stories
October 29, 2013Medical Communications, Sales and Marketing Boehringer, NSCLC, glcc, lung cancer
The Global Lung Cancer Coalition and Boehringer Ingelheim have teamed-up to increase awareness of the challenges facing individuals and families …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
